AAAakriti Adhikari

Aakriti Adhikari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aakriti Adhikari has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Digital Pulmonology Practice with Phonopulmography Leveraging Artificial Intelligence: Future Perspectives Using Dual Microwave Acoustic Sensing and Imaging

    by Arshia K. Sethi, Pratyusha Muddaloor, Priyanka Anvekar, Joshika Agarwal, Anmol Mohan, Mansunderbir Singh, Keerthy Gopalakrishnan, Ashima Yadav, Aakriti Adhikari, Devanshi Damani, et al.

    Respiratory disorders, being one of the leading causes of disability worldwide, account for constant evolution in management technologies, resulting in the incorporation of artificial intelligence (AI) in the recording and analysis of lung sounds to aid diagnosis in clinical pulmonology practice. Although lung sound auscultation is a common clinical practice, its use in diagnosis is limited due to its high variability and subjectivity. We review the origin of lung sounds, various auscultation and processing methods over the years and their clinical applications to understand the potential for a lung sound auscultation and analysis device. Respiratory sounds result from the intra-pulmonary collision of molecules contained in the air, leading to turbulent flow and subsequent sound production. These sounds have been recorded via an electronic stethoscope and analyzed using back-propagation neural networks, wavelet transform models, Gaussian mixture models and recently with machine learning and deep learning models with possible use in asthma, COVID-19, asbestosis and interstitial lung disease. The purpose of this review was to summarize lung sound physiology, recording technologies and diagnostics methods using AI for digital pulmonology practice. Future research and development in recording and analyzing respiratory sounds in real time could revolutionize clinical practice for both the patients and the healthcare personnel.


  • Open Access

    Applications of Microwaves in Medicine Leveraging Artificial Intelligence: Future Perspectives

    by Keerthy Gopalakrishnan, Aakriti Adhikari, Namratha Pallipamu, Mansunderbir Singh, Tasin Nusrat, Sunil Gaddam, Poulami Samaddar, Anjali Rajagopal, Akhila Sai Sree Cherukuri, Anmol Yadav, et al.

    Microwaves are non-ionizing electromagnetic radiation with waves of electrical and magnetic energy transmitted at different frequencies. They are widely used in various industries, including the food industry, telecommunications, weather forecasting, and in the field of medicine. Microwave applications in medicine are relatively a new field of growing interest, with a significant trend in healthcare research and development. The first application of microwaves in medicine dates to the 1980s in the treatment of cancer via ablation therapy; since then, their applications have been expanded. Significant advances have been made in reconstructing microwave data for imaging and sensing applications in the field of healthcare. Artificial intelligence (AI)-enabled microwave systems can be developed to augment healthcare, including clinical decision making, guiding treatment, and increasing resource-efficient facilities. An overview of recent developments in several areas of microwave applications in medicine, namely microwave imaging, dielectric spectroscopy for tissue classification, molecular diagnostics, telemetry, biohazard waste management, diagnostic pathology, biomedical sensor design, drug delivery, ablation treatment, and radiometry, are summarized. In this contribution, we outline the current literature regarding microwave applications and trends across the medical industry and how it sets a platform for creating AI-based microwave solutions for future advancements from both clinical and technical aspects to enhance patient care.


  • Open Access

    Oxygen Requirement and Associated Risk Factors in Post‐COVID‐19 Patients Admitted to a Tertiary Care Center: A Cross‐Sectional Study

    by Bishnu Deep Pathak, Binit Upadhaya Regmi, Sushil Joshi, Bishal Dhakal, Suhail Sapkota, Kanchan Bishwakarma, Ashim Bhandari, Seejan Pathak, Shriya Sharma, Aakriti Adhikari, et al.

    Background. COVID‐19 commonly affects the lungs and may lead to mild to severe hypoxemia. The supplemental oxygen requirement gradually reduces with the improvement in lung pathology. However, a few patients may have exertional desaturation, and ongoing oxygen needs at the time of hospital discharge. The objective of this research was to study the requirement of oxygen therapy in the immediate post‐COVID‐19 period and its associated risk factors. Materials and Methods. An analytical cross‐sectional study was conducted on the admitted post‐COVID‐19 patients who had recently tested real‐time polymerase chain reaction (RT‐PCR) negative in a tertiary care center from August 2021 to mid of October 2021. Nonprobability consecutive sampling was used, and the sample size was 108. The data were analyzed using the Statistical Package for the Social Sciences (IBM‐SPSS), version 23. The mode of oxygen therapy (nasal cannula, face mask, reservoir mask, or mechanical ventilation) in the first two weeks of the study was presented appropriately in a table. The nonparametric statistical tests were applied to determine the association between the duration of post‐COVID‐19 oxygen therapy and several other risk factors such as age, gender, comorbidities, smoking status, exposure to firewood, COVID‐19 vaccination, and severity of COVID‐19. Results. 95 (87.96%) cases required oxygen therapy in their immediate post‐COVID‐19 period. The overall median duration of oxygen therapy was 6.00 (4.00–10.00) days. The nasal cannula was the most commonly used mode of oxygen supplement. The duration of oxygen therapy was significantly higher in patients aged more than 60 years (6.00 [5.00–11.00], p = 0.013), chronic obstructive pulmonary disease (10.00 [6.00–12.75], p = 0.006), history of chronic smoking (9.00 [5.50–13.00], p = 0.044), and severe COVID‐19 infection (7.00 [5.00–10.50], p = 0.042). Conclusions. The proportion of patients requiring oxygen therapy in the immediate post‐COVID‐19 period was higher than that reported in other studies. In addition, old age (>60 years), chronic obstructive pulmonary disease, chronic smoking, and severe COVID‐19 infection significantly increased the duration of oxygen therapy. So, these factors should be assessed while discharging patients from COVID‐19 facilities, and oxygen supplementation should be planned for needy patients.


  • Open Access

    Spontaneous sublingual hematoma secondary to warfarin therapy—A rare complication

    by Aakriti Adhikari, Shriya Sharma, Nirmal Ghimire, Gaurab Mainali, Sumit Kumar Yadav, Ruja Rajkarnikar

    Warfarin is the most commonly prescribed oral anticoagulant in Nepal. It is commonly used for chronic anticoagulation in patients with atrial fibrillation, venous thromboembolism, and artificial heart valves. The major side effect of warfarin is bleeding. Though extremely rare, a sublingual hematoma can lead to life‐threatening complications as it can cause severe airway obstruction. We present a case of a 55‐year‐old female patient who had sublingual hematoma secondary to the use of Warfarin therapy. In addition to the discontinuation of warfarin, she was managed conservatively without any surgical intervention. Early diagnosis, timely discontinuation of the drug, and application of appropriate medical treatment are of utmost importance for reducing morbidity and mortality due to bleeding and airway compromise.


  • Open Access

    Hemophagocytic Lymphohistiocytosis secondary to Rickettsial infection: A case report

    by Shriya Sharma, Aakriti Adhikari, Nirmal Ghimire, Gaurab Mainali, Sumit Kumar Yadav, Prasamsa Pudasaini, Shashank Neupane

    Hemophagocytic Lymphohistiocytosis (HLH) is a rare life‐threatening condition characterized by widespread activation of the immune system leading to tissue damage all over the body. It is divided into primary HLH due to inborn error in lymphocytes, T cells, and macrophages and secondary HLH which is mostly due to infections, systemic connective tissue diseases, and lymphoid malignancies. Here, we report a 34‐year‐old man with a history of high‐grade fever, chills, and rigor, eschar, splenomegaly with the laboratory findings of thrombocytopenia, hypochromic RBCs with anisocytosis and basophilic stippling, elevated transaminases, and a positive Weil Felix test along with positive PCR results for Orientia tsutsugamushi and the presence of IgG and IgM antibodies. A detailed workup was done to rule out other etiology for fever. Diagnosis of HLH secondary to Rickettsia infection was made with a thorough history, clinical evaluation, and a variety of investigations. The patient was treated with Doxycycline, Ciprofloxacin, Etoposide, and Dexamethasone but unfortunately, the patient died during treatment due to multiorgan failure. Patients with scrub typhus typically respond well to therapy; therefore, early detection and antibiotic treatment can help avoid serious complications. Scrub typhus with the hemophagocytic syndrome can result in DIC and multiorgan failure. Despite its rarity, scrub typhus may be lethal; as a result, practitioners must be aware of the necessity of detecting and treating suspected cases as soon as possible. We learned that a systematic diagnostic approach, use of diagnostic criteria, and prompt treatment are very crucial in this disease.


  • Open Access

    Antibiotics Use among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Department of Internal Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study

    by Ushab Rana Mohsin, Nabin Simkhada, Bishnu Deep Pathak, Bishal Dhakal, Binaya Subedi, Dilip Thapa, Bishnu Prasad Shrestha, Om Prakash Tandon, Sanjaya Shrestha, Shriya Sharma, et al.

    Introduction: Acute exacerbation of chronic obstructive pulmonary disease is a life-threatening condition triggered by infections or non-infectious agents. Antibiotics use in such cases prevents severe deterioration and treatment failure. Past studies have shown inappropriate use of antibiotics in different health care settings. The objective of this study was to find out the prevalence of antibiotics use in patients with acute exacerbation of chronic obstructive pulmonary disease in the Department of Internal Medicine of a tertiary care centre. Methods: A descriptive cross-sectional study was conducted among patients with acute exacerbation of Chronic Obstructive Pulmonary Disease admitted to Department of Internal Medicine of a tertiary care centre from 12th February, 2022 to 15th April, 2022 after taking ethical clearance from Institutional Review Committee (Reference number: 417). Convenience sampling was done. Data analysis was done using the Statistical Package for the Social Sciences version 23.0. Point estimate at 95% Confidence Interval was calculated along with frequency and percentage for binary data along with median and interquartile range for continuous data. Results: The prevalence of antibiotics use among study participants was 106 (98.15%) (95.61-100 at a 95% Confidence Interval). Penicillin 82 (75.93%) was the most commonly used antibiotics group. Conclusions: The use of antibiotics in acute exacerbation of chronic obstructive pulmonary disease was higher as compared to other similar studies.